Results 221 to 230 of about 264,807 (314)
A subset of MMR‐proficient colon cancers responds to neoadjuvant immunotherapy
Molecular Oncology, EarlyView.Tan et al. reveal that a distinct subset of early‐stage pMMR colon cancers can respond to neoadjuvant immunotherapy. In the NICHE‐2 trial, responders (26%) were characterized by chromosomal instability, TP53 mutations, and proliferative cell‐cycle programs, whereas nonresponders showed metabolic and stromal reprogramming with TGF‐β‐driven ...
Eleonora Piumatti +3 more
wiley +1 more source
Accurate Determination of the Temperature Sensitivity of UV-Induced Fiber Bragg Gratings. [PDF]
Sensors (Basel)Cosme M +8 more
europepmc +1 more source
Molecular Oncology, EarlyView.The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg +43 more
wiley +1 more source
Ultrasound Biomicroscopy in the Diagnosis and Management of Iris and Ciliary Body Tumors: A Comprehensive Review. [PDF]
Ocul Oncol PatholPrabha D, Singh AD, Raval V.
europepmc +1 more source
Monitoring of the Curing Process for Lining Materials Based on Terahertz Time‐Domain Reflective Spectroscopy [PDF]
Siyi Han +9 more
openalex +1 more source
Molecular Oncology, EarlyView.Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon +13 more
wiley +1 more source
A comprehensive study of plasmonic mode hybridization in gold nanoparticle-over-mirror (NPoM) arrays. [PDF]
NanophotonicsGherman R +10 more
europepmc +1 more source